-
Gabriel tells Brazil to turn the page against Haiti at World Cup
-
Horror injury overshadows Canada's first World Cup win
-
Cuba adopts historic package of free-market reforms
-
Swiss wunderkind Manzambi scores 'childhood dream' brace
-
US faces tough path to new Iran nuclear deal
-
Good US Open shots not good enough for 2-over Scheffler
-
Cuba unveils historic package of free-market reforms
-
Subs send Swiss to World Cup rout of Bosnia-Herzegovina
-
Stokes set for England return in New Zealand finale - reports
-
McIlroy pleased with reduced green speeds in US Open winds
-
Quarantine over for almost all hantavirus ship passengers, crew
-
US stocks resume upward climb as dollar advances again after Fed outlook
-
Ex-presidents and stars, but no Trump, turn out for Obama Library
-
Stevens seizes US Open lead with McIlroy, Aberg one back
-
Al-Qaeda-linked jihadists attack Niger airport, 11 soldiers killed
-
'Big-game' Bellingham shows his worth for England at World Cup
-
New Zealand's Henry rocks England in 2nd Test after Phillips century
-
Vance warns Israel against criticizing US-Iran deal
-
Iran's supreme leader says approved deal as US lifts ports blockade
-
Australian qualifier Hijikata shocks Lehecka at Queen's Club
-
AI-generated videos use Down syndrome to make sales
-
O'Brien's royal century reward for sacrificing all for racing
-
Spurs sign Dutch defender Van Hecke from Brighton
-
England great Botham slams Stokes for breaking curfew
-
Liverpool agree deal to sign Spain forward Munoz from Osasuna
-
Chivu extends Inter deal until 2028 after debut season double triumph
-
New Zealand's Henry rocks England after Phillips century
-
Ghana pushes for concrete slavery reparations
-
Wildcard Eala shocks Rybakina in Berlin
-
Robertson and Scotland eye World Cup history against Morocco
-
South Africa hold Czechs, keep World Cup knockout dream alive
-
Joyful New York celebrates Knicks with ticker-tape parade
-
Important or selfish? World Cup evidence mounts against Ronaldo
-
Europe risks 'total irrelevance' without sovereign tech: Cohere chief
-
EU wrestles over tackling China export flood
-
Ex-presidents, stars, but no Trump, turn out for Obama Center
-
Vance defends Iran deal, eyes Swiss talks
-
US Olympic athlete Simpson shows 'improvement' after collasing on track
-
Wahi granted Canadian visa for Ivory Coast World Cup match after delay
-
Israel FM cuts contact with EU top diplomat over 'apartheid' remarks
-
US lifts Iran ports blockade as uncertainty clouds Swiss Iran talks
-
Brazilian police probe senator close to Lula
-
Brutal Shinnecock winds blow away US Open contenders
-
Leverkusen sign Portuguese talent Moreira from Lyon
-
AI-generated videos wield Down syndrome to make sales
-
Suspected jihadists stage deadly new attack on Niger airport
-
Man dies, trains and classes disrupted as heatwave hits France
-
Oil sinks on Mideast deal, but Fed outlook knocks equities
-
Neymar to miss Brazil's second World Cup game against Haiti
-
Dupont to start for Toulouse in Top 14 semi, Ramos out
US announces new funds for mRNA vaccines, fast tracks bird flu tests
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears loom of another pandemic.
In all, 67 people in the United States have been infected with avian influenza since the outbreak began last year, including an elderly man who died in Louisiana earlier this month.
While the virus has not conclusively been found to spread from person to person, the amount of bird flu circulating among animals and humans has alarmed scientists, because it might combine with seasonal influenza and mutate into a more transmissible form -- potentially triggering a deadly pandemic.
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra.
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. This technology trains the body's immune system using genetic instructions, an approach proven highly effective against Covid. Moderna received $176 million for this effort in July 2024.
The United States also maintains a stockpile of millions of H5N1 vaccine doses based on traditional methods, targeting earlier virus strains but expected to offer solid protection if needed, experts say.
Meanwhile, the Centers for Disease Control and Prevention announced that all positive influenza A tests, especially from hospitalized patients, will be fast-tracked for further testing to check for H5N1.
"H5N1 is a subtype of influenza A," said Nirav Shah, a senior CDC official. Subtyping determines whether the virus is a common seasonal strain or a novel version like H5N1, he explained.
Such testing should ideally be completed within 24 hours, he added, to help researchers understand how the infection occurred, identify potential exposures, and protect health workers.
Until the Louisiana fatality, US cases had been relatively mild. Globally, however, nearly half of the 954 human H5N1 infections recorded since 2003 have been fatal, according to the World Health Organization.
Concerns have also been raised about incoming President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., a vocal critic of vaccines, especially mRNA technology -- widely regarded as a key tool against future pandemics.
He is also a known fan of raw milk, which has repeatedly been found to be contaminated with bird flu from infected dairy cows.
T.Suter--VB